Meta-analyses of HFE variants in coronary heart disease

Gene

Volumn 527, Issue 1, 2013, Pages 167-173

  Lian, Jiangfang ^a   Xu, Limin ^a   Huang, Yi ^a   Le, Yanping ^a   Jiang, Danjie ^a   Yang, Xi ^a   Xu, Weifeng ^a   Huang, Xiaoyan ^a   Dong, Changzheng ^a   Ye, Meng ^a   Zhou, Jianqing ^a   Duan, Shiwei ^a  

^a NINGBO UNIVERSITY   (China)

Author keywords

Coronary heart disease; Hereditary hemochromatosis; HFE; Rs1799945

Indexed keywords

ARTICLE; CHINA; EMBASE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HFE GENE; HUMAN; ISCHEMIC HEART DISEASE; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

95% CI; 95% CONFIDENCE INTERVAL; CHD; CORONARY HEART DISEASE; HARDY-WEINBERG EQUILIBRIUM; HEREDITARY HEMOCHROMATOSIS; HFE; HH; HWE; ODDS RATIO; OR; RS1799945; SINGLE NUCLEOTIDE POLYMORPHISM; SNP;

CASE-CONTROL STUDIES; CORONARY DISEASE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LINKAGE DISEQUILIBRIUM; MEMBRANE PROTEINS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84881221688     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.06.034     Document Type: Article

References (51)

1. Adams P.C., et al. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: the hemochromatosis and iron overload screening study. Circ. Cardiovasc. Genet. 2009, 2:34-37.
2. Anon. Nomenclature and criteria for diagnosis of ischemic heart disease. Circ. Cardiovasc. Genet. 1979, 59:607-609.
3. Battiloro E., Ombres D., Pascale E., D'Ambrosio E., Verna R., Arca M. Haemochromatosis gene mutations and risk of coronary artery disease. Eur. J. Hum. Genet. 2000, 8:389-392.
4. Campbell S., et al. The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart disease. Heart 2003, 89:1023-1026.
5. Candore G., et al. Association between HFE mutations and acute myocardial infarction: a study in patients from Northern and Southern Italy. Blood Cells Mol. Dis. 2003, 31:57-62.
6. Claeys D., Walting M., Julmy F., Wuillemin W.A., Meyer B.J. Haemochromatosis mutations and ferritin in myocardial infarction: a case-control study. Eur. J. Clin. Invest. 2002, 32(Suppl. 1):3-8.
7. Cobbaert C.M., et al. Significance of HFE and FPNI (N144H) gene mutations in the development of cardiovascular disease: results from the Dutch Prospective Monitoring on Cardiovascular Disease Risk Factors. Clin. Chem. 2005, 51. (Suppl., Abstract C-60).
8. Del-Castillo-Rueda A., et al. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis. Gene 2012, 508:15-20.
9. Dunn T., et al. HFE mutations in heart disease. Heart Vessels 2008, 23:348-355.
10. Dupont W.D., Plummer W.D. Power and sample size calculations. A review and computer program. Control. Clin. Trials 1990, 11:116-128.
11. Ellervik C., Tybjaerg-Hansen A., Grande P., Appleyard M., Nordestgaard B.G. Hereditary hemochromatosis and risk of ischemic heart disease: a prospective study and a case-control study. Circ. Cardiovasc. Genet. 2005, 112:185-193.
12. Ellervik C., Tybjaerg-Hansen A., Grande P., Appleyard M., Nordestgaard B.G. Hereditary hemochromatosis and risk of ischemic heart disease: a prospective study and a case-control study. Circulation 2005, 112:185-193.
13. Excoffier L., Lischer H.E. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol. Ecol. Resour. 2010, 10:564-567.
14. Failla M., et al. Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy. Hepatology 2000, 32:569-573.
15. Feder J.N., et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 1996, 13:399-408.
16. Fox C.J., et al. Effects of body iron stores and haemochromatosis genotypes on coronary heart disease outcomes in the Busselton health study. J. Cardiovasc. Risk 2002, 9:287-293.
17. Fujise K., Sherman W. Images in clinical medicine. Coronary arteriovenous fistula on coronary angiography. N. Engl. J. Med. 1994, 331:1265.
18. Gabriel S., Ziaugra L., Tabbaa D. SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr. Protoc. Hum. Genet. 2009, 2.12.1-2.12.16.
19. Gaenzer H., et al. Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J. Am. Coll. Cardiol. 2002, 40:2189-2194.
20. Gunn I.R., Maxwell F.K., Gaffney D., McMahon A.D., Packard C.J. Haemochromatosis gene mutations and risk of coronary heart disease: a west of Scotland coronary prevention study (WOSCOPS) substudy. Heart 2004, 90:304-306.
21. Hannuksela J., et al. Hereditary hemochromatosis gene (HFE) mutations C282Y, H63D and S65C in patients with idiopathic dilated cardiomyopathy. Eur. J. Heart Fail. 2005, 7:103-108.
22. Hanson E.H., Imperatore G., Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Am. J. Epidemiol. 2001, 154:193-206.
23. Hetet G., et al. Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases. Eur. J. Clin. Invest. 2001, 31:382-388.
24. Higgs Z.C., Macafee D.A., Braithwaite B.D., Maxwell-Armstrong C.A. The Seldinger technique: 50years on. Lancet 2005, 366:1407-1409.
25. Kraml P., et al. Ferritin, oxidative stress and coronary atherosclerosis. Vnitr. Lek. 2004, 50:197-202.
26. Lam M., Torbenson M., Yeh M.M., Vivekanandan P., Ferrell L. HFE mutations in alpha-1-antitrypsin deficiency: an examination of cirrhotic explants. Mod. Pathol. 2010, 23:637-643.
27. Larsen L.E., Ellervik C., Appleyard M., Nordestgaard B.G., Birgens H., Tybjaerg-Hansen A. Prevalence of hemochromatosis-associated mutations in the hemochromatosis gene in the Danish population. Ugeskr. Laeger 2002, 164:4545-4547.
28. Mahon N.G., et al. Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy. Heart 2000, 84:541-547.
29. Mascitelli L., Pezzetta F., Goldstein M.R. Body iron stores and gender differences in risk factors for coronary heart disease. Maturitas 2012, 66:107.
30. Moller D.V., et al. Hereditary hemochromatosis (HFE) genotypes in heart failure: relation to etiology and prognosis. BMC Med. Genet. 2010, 11:117.
31. Mura C., Raguenes O., Ferec C. HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 1999, 93:2502-2505.
32. Pardo Silva M.C., et al. HFE gene mutations increase the risk of coronary heart disease in women. Eur. J. Epidemiol. 2010, 25:643-649.
33. Pereira A.C., et al. Hemochromatosis gene variants in patients with cardiomyopathy. Am. J. Cardiol. 2001, 88:388-391.
34. Pietrangelo A. Hereditary hemochromatosis-a new look at an old disease. N. Engl. J. Med. 2004, 350:2383-2397.
35. Qayyum R., Schulman P. Iron and atherosclerosis. Clin. Cardiol. 2005, 28:119-122.
36. Rasmussen M.L., Folsom A.R., Catellier D.J., Tsai M.Y., Garg U., Eckfeldt J.H. A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 2001, 154:739-746.
37. Roest M., et al. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circ. Cardiovasc. Genet. 1999, 100:1268-1273.
38. Salonen J.T., Nyyssonen K., Korpela H., Tuomilehto J., Seppanen R., Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circ. Cardiovasc. Genet. 1992, 86:803-811.
39. Santos M.M., de Sousa M., Rademakers L.H., Clevers H., Marx J.J., Schilham M.W. Iron overload and heart fibrosis in mice deficient for both beta2-microglobulin and Rag1. Am. J. Pathol. 2000, 157:1883-1892.
40. Sham P.C., Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann. Hum. Genet. 1995, 59:97-105.
41. Shi Y., et al. Plasma ferritin levels, genetic variations in HFE gene, and coronary heart disease in Chinese: a case-control study. Atherosclerosis 2011, 218:386-390.
42. Shuler C.O., Black G.B., Jerrell J.M. Population-based treated prevalence of congenital heart disease in a pediatric cohort. Pediatr. Cardiol. 2012, 34:606-611.
43. Sullivan J.L. Iron and the sex difference in heart disease risk. Lancet 1981, 1:1293-1294.
44. Sun Q., Ma J., Rifai N., Franco O.H., Rexrode K.M., Hu F.B. Excessive body iron stores are not associated with risk of coronary heart disease in women. J. Nutr. 2008, 138:2436-2441.
45. Tuomainen T.P., Punnonen K., Nyyssonen K., Salonen J.T. Association between body iron stores and the risk of acute myocardial infarction in men. Circ. Cardiovasc. Genet. 1998, 97:1461-1466.
46. van der A.D., et al. HFE mutations and risk of coronary heart disease in middle-aged women. Eur. J. Clin. Invest. 2006, 36:682-690.
47. van der A.D., et al. Mutations in the HFE gene and cardiovascular disease risk: an individual patient data meta-analysis of 53 880 subjects. Circ. Cardiovasc. Genet. 2008, 1:43-50.
48. Waalen J., Felitti V., Gelbart T., Ho N.J., Beutler E. Prevalence of coronary heart disease associated with HFE mutations in adults attending a health appraisal center. Am. J. Med. 2002, 113:472-479.
49. Wallace D.F., et al. Frequency of the S65C mutation of HFE and iron overload in 309 subjects heterozygous for C282Y. J. Hepatol. 2002, 36:474-479.
50. You S.A., Wang Q. Ferritin in atherosclerosis. Clin. Chim. Acta 2005, 357:1-16.
51. Yu X.Y., et al. An association study of HFE gene mutation with idiopathic male infertility in the Chinese Han population. Asian J. Androl. 2012, 14:599-603.